Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.

导出 LinkOut

翻译打印收藏纠错

作者： Zixiang,Ye ^[1] ; Yaxin,Wu ^[1] ; Yimin,Tu ^[2] ; Mulei,Chen ^[3] ; Yanxiang,Gao ^[4] ; Linying,Shi ^[3] ; Peizhao,Li ^[1] ; Enmin,Xie ^[2] ; Ziyu,Guo ^[1] ; Qing,Li ^[1] ; Xiaozhai,Yu ^[2] ; Yike,Li ^[2] ; Wenquan,Niu ^[4] ; Jingyi,Ren ^[4] ; Jingang,Zheng ^[1]

作者单位： Department of Cardiology, Peking University China-Japan Friendship School of Clinical Medicine, Beijing, China. ^[1] Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. ^[2] Department of Cardiology, Chaoyang Hospital, Capital Medical University, Beijing, China. ^[3] Department of Cardiology, China-Japan Friendship Hospital, Beijing, China. ^[4]

关键词 ABO blood group Gensini score coronary artery disease dialysis end-stage renal disease

DOI 10.3389/fcvm.2021.821540

PMID 35155621

发布时间 2022-05-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in cardiovascular medicine

2021年8卷

821540页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Blood Group O Protect End-Stage Renal Disease Patients With Dialysis From Coronary Artery Disease.

Frontiers in cardiovascular medicine

相似文献

Frontiers in cardiovascular medicine

相关期刊

检索历史清除